Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.08 by 75 percent. This is a 83.33 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $91.592 million which beat the analyst consensus estimate of $91.248 million by 0.38 percent. This is a 19.47 percent decrease over sales of $113.739 million the same period last year.